Sciclone Pharmaceut (SCLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 41,425 | 34,287 | 32,513 | 26,565 | 32,734 |
| Cost of Goods | 7,425 | 6,005 | 5,011 | 4,561 | 6,037 |
| Gross Profit | 34,000 | 28,282 | 27,502 | 22,004 | 26,697 |
| Operating Expenses | 30,849 | 20,180 | 17,873 | 17,904 | 25,919 |
| Operating Income | 3,576 | 8,107 | 9,640 | 4,661 | 815 |
| Interest Expense | 0 | 0 | 19 | 29 | 8 |
| Other Income | 349 | 139 | 53 | -100 | 43 |
| Pre-tax Income | 3,925 | 8,246 | 9,674 | 4,532 | 850 |
| Income Tax | 406 | 331 | 34 | 398 | 814 |
| Net Income Continuous | 3,519 | 7,915 | 9,640 | 4,134 | 36 |
| Net Income | $3,519 | $7,915 | $9,640 | $4,134 | $36 |
| EPS Basic Total Ops | 0.06 | 0.16 | 0.19 | 0.08 | 0.00 |
| EPS Basic Continuous Ops | 0.07 | 0.16 | 0.19 | 0.08 | 0.00 |
| EPS Diluted Total Ops | 0.07 | 0.15 | 0.18 | 0.08 | 0.00 |
| EPS Diluted Continuous Ops | 0.07 | 0.15 | 0.18 | 0.08 | 0.00 |
| EBITDA(a) | $3,776 | $8,328 | $9,864 | $4,868 | $1,030 |